A Phase 1 study of SCY-247 in healthy subjects
Not Yet Recruiting Phase 1 ACTRN12624001392550
Study Description
A study to evaluate the safety, tolerability, and pharmacokinetics of an investigational drug called SCY-247 in healthy individuals
Study Details
- Registry ID:
- ACTRN12624001392550
- Conditions:
- Fungal Infections
- Phase:
- Phase 1
- Target Enrollment:
- 112 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Scientia Clinical Research
Randwick, New South Wales, Australia
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.